Observational studyMedicine2017

PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study.

Davide Bosso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.